DTL
FPRX

Dynamic Technology Lab’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Dynamic Technology Lab’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,121
Closed -$62K – 1479
2020
Q2 		$62K Buy
+10,121
New +$41.7K 0.01% 916
2019
Q1 		– Sell
-13,241
Closed -$123K – 1447
2018
Q4 		$123K Sell
13,241
-423
-3% -$5.03K 0.02% 884
2018
Q3 		$190K Buy
+13,664
New +$203K 0.03% 901
2015
Q4 		– Sell
-14,954
Closed -$230K – 1215
2015
Q3 		$230K Buy
+14,954
New +$321K 0.08% 570

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dynamic Technology Lab's FPRX Position: Q3 2020 in Review

Dynamic Technology Lab sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2020, closing a stake of 10,121 shares — an estimated $62K sold.

Dynamic Technology Lab first reported a position in FPRX in Q3 2015 and held it in 4 quarters. The position peaked at $230K in Q3 2015. 94 funds tracked by Wall St. Rank hold FPRX as of Q3 2020.

  • Dynamic Technology Lab reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 10,121 Five Prime Therapeutics, Inc. shares in Q3 2020, an estimated $62K.
  • Dynamic Technology Lab first reported a position in Five Prime Therapeutics, Inc. in Q3 2015 and held it in 4 quarters.
  • Dynamic Technology Lab's Five Prime Therapeutics, Inc. position peaked at $230K in Q3 2015.
  • 94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2020.

Based on Dynamic Technology Lab's 13F filing for Q3 2020, filed 13 Nov 2020.